Comment on Marra et al. Metastatic Renal Cell Carcinoma to the Soft Tissue 27 Years after Radical Nephrectomy: A Case Report. Medicina 2023, 59, 150
Author Contributions
Funding
Conflicts of Interest
References
- Marra, C.; Losco, L.; Ceccaroni, A.; Pentangelo, P.; Troisi, D.; Alfano, C. Metastatic Renal Cell Carcinoma to the Soft Tissue 27 Years after Radical Nephrectomy: A Case Report. Medicina 2023, 59, 150. [Google Scholar] [CrossRef] [PubMed]
- Leibovich, B.C.; Blute, M.L.; Cheville, J.C.; Cheville, J.C.; Lohse, C.M.; Frank, I.; Kwon, E.D.; Weaver, A.L.; Parker, A.S.; Zincke, H. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: A stratification tool for prospective clinical trials. Cancer 2003, 97, 1663–1671. [Google Scholar] [CrossRef] [PubMed]
- Park, Y.H.; Baik, K.D.; Lee, Y.J.; Ku, J.H.; Kim, H.H.; Kwak, C. Late recurrence of renal cell carcinoma >5 years after surgery: Clinicopathological characteristics and prognosis. BJU Int. 2012, 110, E553–E558. [Google Scholar] [CrossRef] [PubMed]
- Nishii, N.; Shimamoto, H.; Ohsako, T.; Yokokawa, M.; Sato, Y.; Ohata, Y.; Kayamori, K.; Ikeda, T.; Harada, H. Renal cell carcinoma metastasis to the maxillary bone successfully treated with surgery after vascular embolization: A case report. J. Med. Case Rep. 2020, 14, 193. [Google Scholar] [CrossRef] [PubMed]
- Ruiz-Saurí, A.; García-Bustos, V.; Granero, E.; Cuesta, S.; Sales, M.A.; Marcos, V.; Llombart-Bosch, A. Distribution of Vascular Patterns in Different Subtypes of Renal Cell Carcinoma. A Morphometric Study in Two Distinct Types of Blood Vessels. Pathol. Oncol. Res. 2018, 24, 515–524. [Google Scholar] [CrossRef] [PubMed]
- Motzer, R.J.; Hutson, T.E.; Cella, D.; Reeves, J.; Hawkins, R.; Guo, J.; Nathan, P.; Staehler, M.; de Souza, P.; Merchan, J.R.; et al. Pazopanib versus sunitinib in metastatic renal-cell carcinoma. N. Engl. J. Med. 2013, 369, 722–731. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Porta, C.; Ferrari, A.; Czarnecka, A.M.; Szczylik, C.A. Pazopanib in Patients with Clear-Cell Renal Cell Carcinoma: Seeking the Right Patient. Front. Pharmacol. 2017, 8, 329. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
De Luca, P.; de Campora, L.; Camaioni, A. Comment on Marra et al. Metastatic Renal Cell Carcinoma to the Soft Tissue 27 Years after Radical Nephrectomy: A Case Report. Medicina 2023, 59, 150. Medicina 2023, 59, 409. https://doi.org/10.3390/medicina59020409
De Luca P, de Campora L, Camaioni A. Comment on Marra et al. Metastatic Renal Cell Carcinoma to the Soft Tissue 27 Years after Radical Nephrectomy: A Case Report. Medicina 2023, 59, 150. Medicina. 2023; 59(2):409. https://doi.org/10.3390/medicina59020409
Chicago/Turabian StyleDe Luca, Pietro, Luca de Campora, and Angelo Camaioni. 2023. "Comment on Marra et al. Metastatic Renal Cell Carcinoma to the Soft Tissue 27 Years after Radical Nephrectomy: A Case Report. Medicina 2023, 59, 150" Medicina 59, no. 2: 409. https://doi.org/10.3390/medicina59020409